课题基金 / 基金详情

Lynch syndrome-associated endometrial cancer: prevention, screening and prognosis

Lynch syndrome-associated endometrial cancer: prevention, screening and prognosis
林奇综合征相关子宫内膜癌:预防、筛查和预后
批准号:
MR/M018431/1
负责人:
Neil Andrew Ryan
金额:
$27.67万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lynch syndrome is caused by specific gene faults that make cancer more likely to occur. Lynch syndrome runs in families. Bowel cancer and womb cancer are more common in people with Lynch syndrome. When we know someone has Lynch syndrome, we offer colonoscopy, a camera test to look inside the bowel, to remove any bowel polyps before they become cancerous. This has been shown to save lives. To prevent womb cancer, some women have a hysterectomy once their family is complete. Others have womb cancer screening or take hormone treatments, even though we do not know if these things work. As many as 1 in 10 women with womb cancer may have Lynch syndrome, although most do not know it. If they knew about the Lynch syndrome, they may choose to have regular screening by colonoscopy to remove bowel polyps. They may also help other family members find out whether they have Lynch syndrome. Womb cancer that develops in women with Lynch syndrome may behave differently and have a different outlook compared with womb cancer that occurs in women without Lynch syndrome. No one has looked at this before.In this project, I will be conducting three studies: In Study 1, I will see how many patients with womb cancer have Lynch syndrome that they didn't know about. We can find this out by carrying out specific laboratory tests on the tumours. I will look at 200 women who gave blood and tumour samples for future research projects when they came in for their hysterectomy. I will also test 200 women with new diagnoses of womb cancer as they come through the department for their surgery. If the tumour studies suggest that Lynch syndrome may be present, we will carry out blood tests to see if the gene fault is there. This will be done on the stored blood sample or, for current patients, genetic testing will be carried out through the genetic counselling service in our hospital. We will find out how many women with womb cancer have Lynch syndrome. I will also find out how straightforward it is to test women with womb cancer for Lynch syndrome. I will see whether patients are happy for their tumours to be tested for Lynch syndrome and whether they are prepared to go for genetic counselling. I will see whether they want to undergo colonoscopy to identify and treat bowel polyps. I will also see how much screening for Lynch syndrome in women with womb cancer is likely to cost. This will help us develop guidelines for which patients with womb cancer should be tested for Lynch syndrome in the future. In Study 2, I will compare womb cancers from women who have Lynch syndrome with those who do not. Using specialised laboratory techniques, I will look to see how the tumours are different and how they are the same. I will look at whether the women with Lynch syndrome were more or less likely to die from their womb cancer than women without. This will help us understand womb cancer more and inform patients better in the future. Study 3 will look at how effective womb cancer screening and hormone treatments are at preventing womb cancer in women with Lynch syndrome. I will see whether being overweight and inactive make womb cancer more likely in women with Lynch syndrome. This will help us advise women properly when they know they have Lynch syndrome.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1940-6207.capr-21-0229
发表时间: 2021-11
期刊: Cancer prevention research (Philadelphia, Pa.)
影响因子: --
作者: []
通讯作者:
DOI: 10.1136/jmedgenet-2020-107270
发表时间: 2021-10
期刊: Journal of medical genetics
影响因子: 4
作者: [Crosbie EJ, Ryan NAJ, McVey RJ, Lalloo F, Bowers N, Green K, Woodward ER, Clancy T, Bolton J, Wallace AJ, McMahon RF, Evans DG]
通讯作者: Evans DG
DOI: 10.3390/cancers13215444
发表时间: 2021-10-29
期刊: Cancers
影响因子: 5.2
作者: [Barr CE, Njoku K, Hotchkies L, Ryan NAJ, Wan YL, Davies DA, Razvi S, Crosbie EJ]
通讯作者: Crosbie EJ
国内基金
海外基金
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
  • 批准号:
    82371799
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    杨程德
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
  • 批准号:
    82370797
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陶弢
  • 依托单位:
肥大细胞与脂肪细胞互作调控长期高脂饮食小鼠附睾脂肪组织萎缩重构的机制
  • 批准号:
    32070757
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    刘健
  • 依托单位: